Abstract
At the present time, there is no widely agreed definition of postprandial lipaemia (PPL). This lack of a shared definition limits the identification and treatment of patients with exaggerated PPL as well as the evaluation of potential therapeutic agents. PPL is a complex syndrome characterized by non-fasting hypertriglyceridaemia that is associated with an increased risk of vascular events. This review considers the definition of PPL and the methodology for assessing this process.
Original language | English |
---|---|
Journal | Current Vascular Pharmacology |
Volume | 9 |
Issue number | 3 |
Pages (from-to) | 292-301 |
Number of pages | 10 |
ISSN | 1570-1611 |
Publication status | Published - Jun 2011 |